Terms: = Uterine cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Clinical Outcome
16 results:
1. GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
Brooks RA; Tritchler DS; Darcy KM; Lankes HA; Salani R; Sperduto P; Guntupalli S; DiSilvestro P; Kesterson J; Olawaiye AB; Moxley K; Waggoner S; Santin A; Rader JS; Kizer NT; Thaker PH; Powell MA; Mutch DG; Birrer MJ; Goodfellow PJ
Gynecol Oncol; 2019 May; 153(2):335-342. PubMed ID: 30827726
[TBL] [Abstract] [Full Text] [Related]
2. egfr Promoter Methylation, egfr Mutation, and HPV Infection in Chinese Cervical Squamous Cell Carcinoma.
Zhang W; Jiang Y; Yu Q; Qiang S; Liang P; Gao Y; Zhao X; Liu W; Zhang J
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):661-6. PubMed ID: 25789535
[TBL] [Abstract] [Full Text] [Related]
3. Tissue biomarkers as prognostic variables of cervical cancer.
Gadducci A; Guerrieri ME; Greco C
Crit Rev Oncol Hematol; 2013 May; 86(2):104-29. PubMed ID: 23031678
[TBL] [Abstract] [Full Text] [Related]
4. The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma.
Smith HO; Stephens ND; Qualls CR; Fligelman T; Wang T; Lin CY; Burton E; Griffith JK; Pollard JW
Mol Oncol; 2013 Feb; 7(1):41-54. PubMed ID: 22944067
[TBL] [Abstract] [Full Text] [Related]
5. Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.
Halle C; Lando M; Svendsrud DH; Clancy T; Holden M; Sundfør K; Kristensen GB; Holm R; Lyng H
Clin Cancer Res; 2011 Aug; 17(16):5501-12. PubMed ID: 21737508
[TBL] [Abstract] [Full Text] [Related]
6. Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.
Farley J; Sill MW; Birrer M; Walker J; Schilder RJ; Thigpen JT; Coleman RL; Miller BE; Rose PG; Lankes HA
Gynecol Oncol; 2011 May; 121(2):303-8. PubMed ID: 21329967
[TBL] [Abstract] [Full Text] [Related]
7. Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population.
Kitao K; Yoshida S; Kennedy S; Takemura N; Sugimoto M; Deguchi M; Ohara N; Maruo T
Reprod Sci; 2007 May; 14(4):349-57. PubMed ID: 17644807
[TBL] [Abstract] [Full Text] [Related]
8. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract] [Full Text] [Related]
9. uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor immunostaining and epidermal growth factor receptor-tyrosine kinase activity in proliferative and neoplastic human endometrium.
Miturski R; Semczuk A; Postawski K; Jakowicki JA
Tumour Biol; 2000; 21(6):358-66. PubMed ID: 11006576
[TBL] [Abstract] [Full Text] [Related]
11. Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix.
Hove MG; Dinh TV; Hannigan EV; Lucci JA; Chopra V; Smith ER; To T
J Reprod Med; 1999 Jun; 44(6):493-6. PubMed ID: 10394542
[TBL] [Abstract] [Full Text] [Related]
12. Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix.
Pillai MR; Jayaprakash PG; Nair MK
J Cancer Res Clin Oncol; 1998; 124(8):456-61. PubMed ID: 9750023
[TBL] [Abstract] [Full Text] [Related]
13. c-erbb-2 oncoprotein and epidermal growth factor receptor in cervical lesions.
Lakshmi S; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Pathobiology; 1997; 65(3):163-8. PubMed ID: 9309783
[TBL] [Abstract] [Full Text] [Related]
14. c-erbb-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease.
Costa MJ; Walls J; Trelford JD
Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205
[TBL] [Abstract] [Full Text] [Related]
15. [EGF receptor and EGF-like activity as prognostic factors in cervix cancer].
Stellwag B; Scheidel P; Pfeiffer D; Hepp H
Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):177-81. PubMed ID: 8467984
[TBL] [Abstract] [Full Text] [Related]
16. Endometrial cancer: biochemical and clinical correlates.
Gurpide E
J Natl Cancer Inst; 1991 Mar; 83(6):405-16. PubMed ID: 1999848
[TBL] [Abstract] [Full Text] [Related]
